INTRODUCTION
============

Both medical professionals and patients are well aware of the dangers of high cholesterol, but most know little about the risks of low cholesterol, despite the many studies that have examined the issue.^[@r01]--[@r03]^ The first report to show a relationship between low cholesterol and cerebral hemorrhage was a Japanese cohort study,^[@r04]^ and many subsequent observational studies have shown that low cholesterol is associated with cerebral hemorrhage,^[@r05]^ cancer, suicide, injury, and non-coronary mortality.^[@r06]--[@r08]^ However, there is no explicit evidence that these relationships are causal.

A meta-analysis of interventional trials showed that cholesterol-lowering therapy was associated with high mortality in a population with low cardiovascular risk.^[@r09]^ Although this meta-analysis focused on interventions other than statins, studies of statins have also shown that statin administration is associated with increases in cancer incidence among elderly adults,^[@r10]^ breast cancer incidence during the secondary prevention phase,^[@r11]^ and total cancer incidence.^[@r12]^

Japanese researchers reported that the relationship between low cholesterol and mortality disappeared when deaths due to liver disease were excluded.^[@r13]^

To clarify this issue, we investigated the relationship between cholesterol and mortality with respect to cause of death (deaths due to stroke, heart disease, and cancer). In addition, the relationship between cholesterol and mortality was examined after excluding deaths due to liver disease.

METHODS
=======

Participants
------------

This study was conducted as part of the Jichi Medical School (JMS) Cohort Study^[@r13]^; 12 490 men and women aged 40 to 69 years participated. The JMS Cohort Study is a prospective cohort study that began in 1992 with the aim of investigating risk factors for stroke and cardiovascular diseases. We collected baseline data from April 1992 through July 1995 in 12 rural areas of Japan and completed a follow-up in December 2005, in which 65% of the subjects from mass screening examinations participated. Of these, 96% of participants completed follow-up; incomplete data were obtained for 409 participants who were not followed until the last day of our study because they had left the study area. There were no follow-up data for 97 participants. However, data from the abovementioned 409 subjects were included in the analyses, and the day they left the area was defined as the endpoint. Informed consent for follow-up was not obtained from 95 participants and from 2 additional participants who had already left the area at the beginning of follow-up. These 97 individuals were excluded from the analyses. Furthermore, we were unable to obtain total cholesterol data for 156 participants, including 4 who did not provide informed consent. In total, we analyzed data from 12 241 participants, ie, 98% of the total number of participants. The average follow-up period was 11.9 years. We observed participants for a total of 145 312 person-years. Details regarding the JMS Cohort Study are available elsewhere.^[@r14]^

Exposure
--------

Total cholesterol was measured by an enzymatic method (Wako, Osaka, Japan; interassay coefficient of variation: 1.5%). All samples were measured at the same laboratory (SRL, Tokyo, Japan).

Confounding factors
-------------------

We obtained information on confounding factors (smoking and drinking habits, blood pressure, height, weight, and high-density lipoprotein \[HDL\] cholesterol) from the baseline data of the JMS Cohort Study.

Outcome
-------

Information regarding cause of death was collected using data from death certificates and national vital statistics with the permission of the Agency of General Affairs.

We classified cause of death according to the International Classification of Diseases, 10th Revision (hemorrhagic stroke: I60, I61, I69.0, I69.1; ischemic stroke: I63, I69.3; myocardial infarction: I21, I22; heart failure: I50).

Written informed consent was obtained from all participants. The Institutional Review Board of JMS was responsible for ethical review of this research and approved the study.

Statistical analysis
--------------------

Because the relationship between cholesterol and mortality is not linear, subjects were divided into 4 groups according to total cholesterol level (\<4.14 mmol/L, 4.14 mmol/L to \<5.17 mmol/L, 5.17 mmol/L to \<6.21 mmol/L, and ≥6.21 mmol/L). The second lowest group (4.14 mmol/L to \<5.17 mmol/L) was used as the reference group. However, in the analyses of ischemic stroke in men and myocardial infarction in women, the highest group was defined as ≥5.70 mmol/L because there was no ischemic stroke or myocardial infarction in subjects with a total cholesterol level ≥6.21 mmol/L. The cutoff value used for the lowest group was selected on the basis of past research,^[@r01]^ and the cutoff value for the highest group was based on criteria from the mass screening examination.

A Cox proportional hazards model was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality. Both age-adjusted HRs and multivariate-adjusted HRs were calculated. The multivariate-adjusted model adjusted for age, smoking status (current/former/never), drinking status (current/former/never), systolic blood pressure, HDL cholesterol, and body mass index (BMI:\<18, 18 to \<22, 22 to \<26, ≥26). Age, blood pressure, and HDL cholesterol were analyzed as continuous variables. All analyses were performed separately for each sex using STATA/SE for Windows (STATACORP, release 10, TX, USA). A *P* value of less than 0.05 was considered to indicate statistical significance.

RESULTS
=======

All subjects were included in the age-adjusted analysis. Because of missing values, multivariate-adjusted analyses included data from only 11 869 subjects. Tables [1](#tbl01){ref-type="table"} and [2](#tbl02){ref-type="table"} show the baseline characteristics of subjects grouped by sex and cholesterol category. The background characteristics of subjects included and excluded from the multivariate-adjusted analysis did not differ.

###### Baseline characteristics of participants

  ------------------------------------------------------------------------
  Variable                     Men    Women                         
  ---------------------------- ------ ------- ------ ------ ------- ------
  Age                          4839   55.2    12     7495   55.3    11.3

  Height\                      4649   162.5   6.9    7250   150.3   6.2
  (cm)                                                              

  Body weight\                 4651   60.9    9.4    7252   52.4    8.0
  (kg)                                                              

  Systolic BP\                 4664   131.5   20.5   7297   128.3   21.0
  (mm Hg)                                                           

  Diastolic BP (mm Hg)         4664   79.2    12.3   7297   76.3    12.1

  Total cholesterol (mmol/L)   4839   4.8     0.9    7495   5.1     0.9

  HDL cholesterol (mmol/L)     4839   1.3     0.4    7495   1.4     0.3

  Body mass index (kg/m^2^)    4649   23.0    2.9    7250   23.2    3.2

                                                                    

  Smoking                      *n*    \%             *n*    \%       

                                                                    

   Current                     2280   50.5           384    5.5      

   Former                      1274   28.2           195    2.8      

   Never                       957    21.2           6362   91.7     

  Drinking                                                           

   Current                     3293   75.0           1692   25.0     

   Former                      161    3.7            103    1.5      

   Never                       935    21.3           4983   73.5     
  ------------------------------------------------------------------------

Abbreviations: BP, blood pressure; HDL, high-density lipoprotein.

###### Baseline characteristics of participants by cholesterol level

  **Men**                                                                                                                          
  --------------------------- --------- -------------- ------ -------------- ------ -------------- ------ -------------- --------- ---------
  Age                         1136      55.3 (13.2)    2142   55.6 (11.8)    1274   54.9 (11.5)    287    53.0 (10.7)    0.038     
  Height (cm)                 1079      162.4 (7.2)    2068   162.3 (6.8)    1225   162.8 (6.9)    277    163.4 (6.4)    \<.0001   
  Body weight (kg)            1081      58.6 (9.0)     2068   60.5 (9.1)     1225   62.8 (9.6)     277    64.3 (9.8)     \<.0001   
  Systolic BP (mm Hg)         1095      129.0 (20.9)   2069   131.3 (20.2)   1224   133.4 (20.5)   276    134.5 (20.4)   \<.0001   
  Diastolic BP (mm Hg)        1095      77.2 (12.1)    2069   79.1 (12.1)    1224   80.8 (12.4)    276    81.3 (12.0)    \<.0001   
  HDL cholesterol (mmol/L)    1136      1.2 (0.3)      2142   1.3 (0.3)      1274   1.3 (0.4)      287    1.3 (0.4)      \<.0001   
  Body mass index (kg/m^2^)   1079      22.2 (2.7)     2068   22.9 (2.8)     1225   23.6 (3.0)     277    24 (2.9)       \<.0001   
                                                                                                                                   
                                        *n*            \%     *n*            \%     *n*            \%     *n*            \%        *P*^b^
                                                                                                                                   
  Smoking                     Current   627            59.1   986            49.3   532            45.2   135            49.5      \<.0001
                              Former    227            21.4   579            29.0   389            33.1   79             28.9       
                              Never     207            19.5   435            21.8   256            21.8   59             21.6       
                                                                                                                                   
  Drinking                    Current   760            74.4   1461           75.1   871            75.6   201            74.4      0.628
                              Former    47             4.6    66             3.4    41             3.6    7              2.6        
                              Never     215            21.0   418            21.5   240            20.8   62             23.0       
                                                                                                                                   

  **Women**                                                                                                                        
  --------------------------- --------- -------------- ------ -------------- ------ -------------- ------ -------------- --------- ---------
  Age                         1077      48.2 (12.7)    3050   54.4 (11.7)    2522   58.3 (9.4)     846    59.1 (7.9)     \<.0001   
  Height (cm)                 1012      152.0 (6.7)    2944   150.7 (6.2)    2463   149.4 (5.9)    831    149.3 (5.5)    \<.0001   
  Body weight (kg)            1012      51.4 (7.7)     2944   52.2 (8.0)     2463   52.7 (8.1)     831    53.2 (7.9)     \<.0001   
  Systolic BP^a^ (mm Hg)      1030      118.8 (18.8)   2961   126.6 (20.7)   2471   131.8 (20.9)   835    135.6 (20.4)   \<.0001   
  Diastolic BP^a^ (mm Hg)     1030      71.2 (11.5)    2961   75.4 (11.8)    2471   78.2 (11.9)    835    80.4 (11.9)    \<.0001   
  HDL cholesterol (mmol/L)    1077      1.2 (0.3)      3050   1.4 (0.3)      2522   1.4 (0.3)      846    1.4 (0.4)      \<.0001   
  Body mass index (kg/m^2^)   1012      22.3 (3.1)     2944   23 (3.1)       2463   23.6 (3.2)     831    23.8 (3.1)     \<.0001   
                                                                                                                                   
                                        *n*            \%     *n*            \%     *n*            \%     *n*            \%        *P*^b^
                                                                                                                                   
  Smoking                     Current   79             8.1    171            6.0    100            4.3    39             4.3       \<.0001
                              Former    48             4.9    76             2.7    53             2.3    19             2.3        
                              Never     853            87.0   2591           91.3   2184           93.5   790            93.5       
                                                                                                                                   
  Drinking                    Current   289            30.5   730            26.5   516            22.5   177            21.1      \<.0001
                              Former    14             1.5    34             1.2    45             2.0    10             1.2        
                              Never     644            68.0   1992           72.3   1735           75.6   652            77.7       

Abbreviations: BP, blood pressure; HDL, high-density lipoprotein.

^a^One-way analysis of variance.

^b^Chi-square test.

In total, 635 men and 423 women died during the study period; 34 male deaths and 15 female deaths were due to liver diseases. Table [3a](#tbl3a){ref-type="table"} shows the number of deaths according to cause of death, including deaths due to liver disease, and incidence in each cholesterol group by sex. Liver cancer and hepatic failure were the main causes of death due to liver disease.

###### Causes of death

  Cause of death   Men   Women         
  ---------------- ----- ------- ----- ------
  Stroke           67    10.6    60    14.4
   SAH             7     1.1     17    4.0
   infarction      36    5.7     28    6.6
   hemorrhage      20    3.1     13    3.0
   other           4     0.6     2     0.5
  Heart disease    73    11.5    60    14.2
   infarction      31    4.9     27    6.0
   heart failure   20    3.1     13    3.0
   other           22    3.5     20    4.7
  Cancer^a^        240   37.9    154   36.0
   lung            69    10.9    21    5.0
   stomach         26    4.1     22    5.0
   colon           17    2.7     18    4.2
   other           128   20.1    93    22.0
  Other            255   40.1    149   34.7
   pneumonia       67    10.6    25    5.9
   suicide         24    3.8     17    4.0
   accident        30    4.7     7     1.7
   other           133   20.9    100   23.6
                                       
  Total            635   100     423   100
                                       
  Liver disease                         
   cancer          16    47.1    3     20.0
   liver failure   14    41.2    11    73.3
   other           4     11.7    1     6.7
                                       
   Total           34    100     15    100

Abbreviation: SAH, subarachnoid hemorrhage.

^a^Including liver cancer.

###### Mortality by total cholesterol level

                            Total cholesterol level (mmol/L)                                            
  ------------------------- ---------------------------------- ------- ----- ------- ----- ------- ---- ------
  **Men**                                                                                               
  Total mortality           195                                15.08   258   10.27   152   10.10   30   8.77
  Stroke mortality          19                                 1.47    29    1.15    16    1.06    3    0.88
   Hemorrhagic stroke       10                                 0.77    10    0.40    4     0.27    2    0.58
   Ischemic stroke          7                                  0.54    17    0.68    12    0.80    0    0.00
  Heart disease mortality   21                                 1.62    22    0.88    15    1.00    4    1.17
   Myocardial infarction    9                                  0.70    13    0.52    6     0.40    2    0.58
   Heart failure^b^         5                                  0.39    6     0.24    6     0.40    2    0.58
  Cancer mortality          80                                 6.19    91    3.62    59    3.92    10   2.92
                                                                                                        
  **Women**                                                                                             
  Total mortality           53                                 4.25    169   4.68    151   5.01    50   4.95
  Stroke mortality          6                                  0.48    21    0.58    24    0.80    9    0.89
   Hemorrhagic stroke       5                                  0.40    6     0.17    13    0.43    5    0.50
   Ischemic stroke          1                                  0.08    12    0.33    11    0.37    4    0.40
  Heart disease mortality   7                                  0.56    26    0.72    17    0.56    5    0.50
   Myocardial infarction    3                                  0.24    15    0.42    9     0.30    0    0.00
   Heart failure^b^         4                                  0.32    3     0.08    2     0.07    3    0.30
  Cancer mortality          19                                 1.52    53    1.47    56    1.86    26   2.58

^a^per 1000 person-years.

^b^excluding myocardial infarction.

Table [4a](#tbl4a){ref-type="table"} shows HRs and 95% CIs for mortality by cholesterol category. Crude, age-adjusted, and multivariate-adjusted HRs are grouped by sex. Smoking status, drinking status, and BMI were entered into the models as categorical dummy variables. The multivariate-adjusted HR of the lowest cholesterol group (\<4.14 mmol/L) was 1.38 (95% CI, 1.13--1.66) for men and 1.42 (1.02--2.00) for women. The HRs of men and women in the highest cholesterol group (≥6.21 mmol/L) were not significant; the HR was less than 1 for women (HR, 0.93; 95% CI, 0.67--1.30).

###### Total cholesterol level and mortality

  ----------------------------------------------------------------------------------------------------------------------
                                          Total cholesterol level (mmol/L)                           
  --------------------------------------- ---------------------------------- --- ------------------- -------------------
  **Men**                                                                                             

  Total mortality                                                                                     

   Crude                                  1.48 (1.23--1.78)                  1   0.98 (0.80--1.20)   0.85 (0.58--1.23)

   Age-adjusted                           1.49 (1.23--1.79)                  1   1.04 (0.85--1.27)   1.12 (0.77--1.64)

   Multivariate-\                         1.38 (1.13--1.66)                  1   1.09 (0.88--1.34)   1.21 (0.82--1.78)
  ​ adjusted^a^                                                                                      

                                                                                                     

  Excluding deaths due to liver disease                                                              

   Crude                                  1.37 (1.13--1.66)                  1   0.99 (0.81--1.22)   0.87 (0.60--1.28)

   Age-adjusted                           1.38 (1.13--1.67)                  1   1.06 (0.86--1.29)   1.16 (0.80--1.71)

   Multivariate-\                         1.27 (1.03--1.56)                  1   1.10 (0.89--1.36)   1.25 (0.85--1.85)
  ​ adjusted^a^                                                                                      

                                                                                                     

  **Women**                                                                                           

  Total mortality                                                                                     

   Crude                                  0.92 (0.67--1.25)                  1   1.07 (0.86--1.33)   1.06 (0.77--1.45)

   Age-adjusted                           1.50 (1.10--2.04)                  1   0.92 (0.74--1.14)   0.97 (0.67--1.26)

   Multivariate-\                         1.42 (1.02--2.00)                  1   0.93 (0.73--1.17)   0.93 (0.67--1.30)
  ​ adjusted^a^                                                                                      

                                                                                                     

  Excluding deaths due to liver disease                                                              

   Crude                                  0.91 (0.66--1.24)                  1   1.06 (0.85--1.32)   1.04 (0.76--1.44)

   Age-adjusted                           1.49 (1.09--2.04)                  1   0.91 (0.72--1.14)   0.91 (0.66--1.26)

   Multivariate-\                         1.40 (0.99--1.98)                  1   0.92 (0.72--1.17)   0.93 (0.66--1.31)
  ​ adjusted^a^                                                                                      
  ----------------------------------------------------------------------------------------------------------------------

^a^Cox proportional hazards model adjusted for age, systolic blood pressure, high-density lipoprotein cholesterol, smoking, drinking, and body mass index.

Among women, there was an inverse association between total cholesterol and mortality age-adjusted analysis. The multifactor-adjusted HR in the lowest cholesterol group was 0.50 (95% CI, 0.16--1.55) in premenopausal women and 1.42 (0.98--2.06) in postmenopausal women.

Table [4a](#tbl4a){ref-type="table"} shows the same results, after excluding deaths due to liver disease. In these analyses, the age-adjusted HRs of the lowest cholesterol group were statistically significant: 1.38 (1.13--1.67) for men and 1.49 (1.09--2.04) for women. There was no difference between these results and those for all causes of mortality.

The results of analyses that excluded deaths within the first 5 years of follow-up were similar to those that included all deaths (Table [4b](#tbl4b){ref-type="table"}). In addition, the results of analysis that excluded 320 participants with a history of stroke (113), myocardial infarction (65), or cancer (142) were similar (Table [4c](#tbl4c){ref-type="table"}).

###### Total cholesterol and mortality (excluding deaths within the first 5 years of follow-up)

  ----------------------------------------------------------------------------------------------------------------------
                                          Total cholesterol level (mmol/L)                           
  --------------------------------------- ---------------------------------- --- ------------------- -------------------
  **Men**                                                                                             

  Total mortality                                                                                     

   Crude                                  1.43 (1.16--1.79)                  1   1.01 (0.80--1.27)   0.91 (0.60--1.40)

   Age-adjusted                           1.47 (1.18--1.83)                  1   1.07 (0.85--1.35)   1.24 (0.81--1.89)

   Multivariate-\                         1.39 (1.10--1.74)                  1   1.07 (0.84--1.37)   1.33 (0.87--2.05)
  ​ adjusted^a^                                                                                      

                                                                                                     

  Excluding deaths due to liver disease                                                              

   Crude                                  1.33 (1.06--1.68)                  1   1.03 (0.82--1.30)   0.94 (0.62--1.44)

   Age-adjusted                           1.36 (1.08--1.71)                  1   1.09 (0.87--1.38)   1.28 (0.84--1.97)

   Multivariate-\                         1.27 (1.00--1.62)                  1   1.11 (0.87--1.41)   1.39 (0.90--2.14)
  ​ adjusted^a^                                                                                      

                                                                                                     

  **Women**                                                                                           

  Total mortality                                                                                     

   Crude                                  0.82 (0.57--1.20)                  1   0.99 (0.77--1.29)   1.14 (0.80--1.63)

   Age-adjusted                           1.37 (0.94--2.00)                  1   0.86 (0.66--1.11)   0.99 (0.70--1.43)

   Multivariate-\                         1.24 (0.82--1.88)                  1   0.92 (0.70--1.22)   1.11 (0.76--1.61)
  ​ adjusted^a^                                                                                      

                                                                                                     

  Excluding deaths due to liver disease                                                              

   Crude                                  0.80 (0.55--1.18)                  1   0.99 (0.76--1.30)   1.15 (0.80--1.65)

   Age-adjusted                           1.34 (0.91--1.98)                  1   0.86 (0.66--1.12)   0.91 (0.66--1.26)

   Multivariate-\                         1.20 (0.79--1.84)                  1   0.92 (0.70--1.23)   0.93 (0.66--1.31)
  ​ adjusted^a^                                                                                      
  ----------------------------------------------------------------------------------------------------------------------

^a^Cox proportional hazards model adjusted for age, systolic blood pressure, high-density lipoprotein cholesterol, smoking, drinking, and body mass index.

###### Total cholesterol and mortality (excluding participants with a history of cancer, stroke, or myocardial infarction)

  -----------------------------------------------------------------------------------------------------------------------
                                          Total cholesterol levels (mmol/L)                           
  --------------------------------------- ----------------------------------- --- ------------------- -------------------
  **Men**                                                                                              

  Total mortality                                                                                      

   Crude                                  1.49 (1.21--1.83)                   1   0.96 (0.76--1.19)   0.87 (0.60--1.27)

   Age-adjusted                           1.48 (1.21--1.82)                   1   1.02 (0.81--1.27)   1.06 (0.73--1.55)

   Multivariate-\                         1.38 (1.12--1.71)                   1   1.08 (0.86--1.36)   1.25 (0.83--1.87)
  ​ adjusted^a^                                                                                       

                                                                                                      

  Excluding deaths due to liver disease                                                               

   Crude                                  1.39 (1.12--1.72)                   1   0.98 (0.78--1.23)   0.91 (0.62--1.33)

   Age-adjusted                           1.38 (1.13--1.71)                   1   1.04 (0.83--1.31)   1.11 (0.76--1.62)

   Multivariate-\                         1.29 (1.03--1.60)                   1   1.10 (0.88--1.39)   1.30 (0.87--1.94)
  ​ adjusted^a^                                                                                       

                                                                                                      

  **Women**                                                                                            

  Total mortality                                                                                      

   Crude                                  0.77 (0.53--1.12)                   1   1.16 (0.92--1.47)   1.09 (0.78--1.53)

   Age-adjusted                           1.29 (0.89--1.88)                   1   0.96 (0.76--1.22)   0.90 (0.64--1.26)

   Multivariate-\                         1.28 (0.88--1.89)                   1   0.99 (0.78--1.27)   0.90 (0.63--1.30)
  ​ adjusted^a^                                                                                       

                                                                                                      

  Excluding deaths due to liver disease                                                               

   Crude                                  0.78 (0.53--1.14)                   1   1.15 (0.90--1.47)   1.08 (0.77--1.53)

   Age-adjusted                           1.30 (0.89--1.91)                   1   0.95 (0.75--1.22)   0.89 (0.63--1.26)

   Multivariate-\                         1.29 (0.88--1.91)                   1   0.99 (0.77--1.27)   0.90 (0.62--1.30)
  ​ adjusted^a^                                                                                       
  -----------------------------------------------------------------------------------------------------------------------

^a^Cox proportional hazards model adjusted for age, systolic blood pressure, high-density lipoprotein cholesterol, smoking, drinking, and body mass index.

Table [5](#tbl05){ref-type="table"} shows HRs and 95% CIs for stroke, heart disease, and cancer mortality according to cholesterol category. The multivariate-adjusted HR of the lowest cholesterol group was higher than 1 for each cause of death and was statistically significant for cancer mortality in men.

###### Total cholesterol by cause of death

                               Total cholesterol level (mmol/L)                           
  ---------------------------- ---------------------------------- --- ------------------- --------------------
  **Men**                                                                                  
  Stroke mortality                                                                         
    Crude                      1.23 (0.72--2.27)                  1   0.92 (0.50--1.69)   0.75 (0.23--2.49)
    Age-adjusted               1.28 (0.72--2.28)                  1   0.98 (0.53--1.80)   1.02 (0.31--3.34)
    Multivariate-adjusted^a^   1.21 (0.66--2.21)                  1   0.99 (0.53--1.82)   0.98 (0.29--3.23)
   Hemorrhagic stroke                                                                      
    Crude                      1.93 (0.81--4.62)                  1   0.65 (0.21--2.01)   1.79 (0.50--6.45)
    Age-adjusted               1.92 (0.80--4.61)                  1   0.69 (0.22--2.19)   2.10 (0.58--7.61)
    Multivariate-adjusted^a^   1.96 (0.80--4.79)                  1   0.68 (0.21--2.16)   1.76 (0.38--8.09)
   Ischemic stroke^b^                                                                      
    Crude                      0.84 (0.35--2.04)                  1   1.56 (0.71--3.40)   0.48 (0.14--1.64)
    Age-adjusted               0.85 (0.35--2.06)                  1   1.59 (0.73--3.47)   0.58 (0.17--1.95)
    Multivariate-adjusted^a^   0.79 (0.30--2.04)                  1   1.55 (0.70--3.43)   0.65 (0.19--2.23)
  Heart disease mortality                                                                  
    Crude                      1.74 (1.00--3.01)                  1   1.06 (0.58--1.93)   1.36 (0.54--3.53)
    Age-adjusted               1.75 (1.01--3.04)                  1   1.14 (0.62--2.10)   1.93 (0.74--5.03)
    Multivariate-adjusted^a^   1.36 (0.76--2.46)                  1   1.04 (0.54--2.01)   2.14 (0.81--5.65)
   Myocardial infarction                                                                   
    Crude                      1.34 (0.57--3.12)                  1   0.76 (0.29--1.99)   1.38 (0.40--4.82)
    Age-adjusted               1.34 (0.58--3.15)                  1   0.84 (0.32--2.19)   1.84 (0.53--6.483)
    Multivariate-adjusted^a^   0.99 (0.40--2.46)                  1   0.86 (0.30--2.47)   2.37 (0.52--10.83)
   Heart failure^c^                                                                        
    Crude                      1.63 (0.50--5.32)                  1   1.64 (0.54--5.01)   1.94 (0.40--9.40)
    Age-adjusted               1.72 (0.52--5.66)                  1   1.90 (0.61--5.89)   2.77 (0.56--13.67)
    Multivariate-adjusted^a^   1.32 (0.36--4.79)                  1   1.59 (0.48--5.27)   3.86 (0.76--19.58)
  Cancer mortality                                                                         
    Crude                      1.72 (1.27--2.32)                  1   1.08 (0.78--1.49)   0.80 (0.42--1.53)
    Age-adjusted               1.73 (1.28--2.34)                  1   1.13 (0.82--1.57)   1.01 (0.53--1.95)
    Multivariate-adjusted^a^   1.66 (1.22--2.27)                  1   1.18 (0.85--1.66)   1.07 (0.55--2.07)
                                                                                          
  **Women**                                                                                
  Stroke mortality                                                                         
    Crude                      0.83 (0.33--2.05)                  1   1.37 (0.76--2.46)   1.53 (0.70--3.35)
    Age-adjusted               1.41 (0.57--3.50)                  1   1.19 (0.66--2.15)   1.40 (0.64--3.06)
    Multivariate-adjusted^a^   1.84 (0.71--4.76)                  1   1.29 (0.68--2.44)   1.52 (0.66--3.48)
   Hemorrhagic stroke                                                                      
    Crude                      2.18 (0.70--6.81)                  1   2.22 (0.92--5.37)   3.28 (1.21--8.87)
    Age-adjusted               3.41 (1.07--10.85)                 1   1.97 (0.80--4.85)   2.92 (1.05--8.07)
    Multivariate-adjusted^a^   3.86 (1.18--12.68)                 1   1.94 (0.77--4.89)   2.15 (0.68--6.77)
   Ischemic stroke                                                                         
    Crude                      0.23 (0.03--1.81)                  1   1.06 (0.48--2.39)   1.08 (0.35--3.28)
    Age-adjusted               0.44 (0.06--3.39)                  1   0.99 (0.44--2.23)   1.06 (0.34--3.28)
    Multivariate-adjusted^a^   0.57 (0.07--4.54)                  1   0.90 (0.37--2.19)   1.17 (0.36--3.85)
  Heart disease mortality                                                                  
    Crude                      0.75 (0.33--1.73)                  1   0.93 (0.53--1.65)   0.66 (0.26--1.73)
    Age-adjusted               1.43 (0.62--3.40)                  1   0.87 (0.50--1.55)   0.69 (0.26--1.80)
    Multivariate-adjusted^a^   1.34 (0.54--3.35)                  1   0.78 (0.42--1.42)   0.39 (0.11--1.30)
   Myocardial infarction^b^                                                                
    Crude                      0.58 (0.17--2.01)                  1   0.51 (0.17--1.53)   0.53 (0.20--1.46)
    Age-adjusted               1.09 (0.31--3.78)                  1   0.50 (0.16--1.49)   0.49 (0.18--1.36)
    Multivariate-adjusted^a^   1.07 (0.30--3.79)                  1   0.38 (0.11--1.34)   0.52 (0.18--1.46)
   Heart failure^c^                                                                        
    Crude                      3.75 (0.87--16.19)                 1   0.71 (0.13--3.99)   4.22 (1.00--17.82)
    Age-adjusted               6.57 (1.49--28.97)                 1   0.66 (0.11--3.77)   4.00 (0.92--17.45)
    Multivariate-adjusted^a^   5.79 (1.07--31.27)                 1   0.72 (0.12--4.28)   2.33 (0.37--14.66)
  Cancer mortality                                                                         
    Crude                      1.04 (0.62--1.76)                  1   1.26 (0.87--1.84)   1.75 (1.09--2.80)
    Age-adjusted               1.50 (0.89--2.55)                  1   1.09 (0.75--1.58)   1.48 (0.92--2.36)
    Multivariate-adjusted^a^   1.44 (0.83--2.49)                  1   1.07 (0.72--1.59)   1.58 (0.97--2.56)

^a^Cox proportional hazards model adjusted for age, systolic blood pressure, high-density lipoprotein cholesterol, smoking, drinking, and body mass index.

^b^Cholesterol levels: \<4.13, 4.14--5.16, 5.17--5.69, ≥5.70.

^c^Excluding myocardial infarction.

We separately analyzed participants with and without ischemia for stroke and heart disease. Among subjects with the highest level of total cholesterol, the multivariate-adjusted HRs for ischemic stroke and myocardial infarction were not significant. The corresponding HRs for ischemic stroke in men and myocardial infarction in women were less than 1; however, the HR of the lowest group was 3.86 (95% CI, 1.18--12.68) for hemorrhagic stroke in women and 5.79 (1.07--31.27) for heart failure excluding myocardial infarction in women.

DISCUSSION
==========

We noted a clear relationship between low cholesterol and increased mortality. Okamura et al^[@r13]^ reported that occult liver diseases are associated with mortality; however, in the present study, the relationship between low cholesterol and increased mortality was unchanged in analyses that excluded deaths due to liver disease. Our results suggest that hemorrhagic stroke and heart failure excluding myocardial infarction, contribute to the relationship between low cholesterol and high mortality.

Studies have shown a relationship between low cholesterol and non-cardiovascular mortality; however, in addition to cancer mortality, stroke mortality and heart disease mortality were also related to low cholesterol in our analyses. The relationship between low cholesterol and hemorrhagic stroke was similar to previously reported results.^[@r03],[@r05]^ Although the relationship between high cholesterol and ischemic stroke is not constant, it may be that the risk of high cholesterol disappears due to medical interventions for ischemic stroke and that the risk of low cholesterol is thus emphasized because of a lack of such interventions for low cholesterol.

It is difficult to interpret the relationship between low cholesterol and heart disease mortality. Although a relationship between cholesterol and heart failure was reported, high cholesterol, too, was a risk factor for non-ischemic heart failure.^[@r16]^ We found no report of an association between low cholesterol and heart failure. The effects of malnutrition should be considered, as should the possible presence of beriberi heart disease and alcoholism. The relationship between low cholesterol and heart disease mortality was stronger in women than in men, so a disease like hyperthyroidism, which is more common in women, may be the culprit. A meta-analysis found an increase in cardiovascular mortality associated with subclinical hyperthyroidism,^[@r17]^ but further investigations are necessary to confirm this hypothesis.

Because low cholesterol is associated with high cancer mortality, low cholesterol is a key finding in cancer. Previous studies reported an increase in liver cancer^[@r13],[@r15]^; however, in the present study, increased cancer mortality in the lowest cholesterol group was unchanged after excluding cases of liver disease from the analyses. This suggests a need for screening of cancers other than liver cancer in individuals with low cholesterol levels.

Our results differ from those of previous studies,^[@r01],[@r03]^ in that high cholesterol was not identified as a risk factor for mortality in the present study. The HR was 0.93 (0.67--1.30) for women, which indicates that the focus should be on adults with low cholesterol rather than those with high cholesterol.

Our analyses constitute a primary use of existing data. An important advantage of this study was that the follow-up rate was very high because the study was conducted in rural areas, where migration is far less than in urban areas.

Cause of death was ascertained using death certificates, so there were potential limitations in accuracy regarding cause of death. The setting was a periodical health examination to screen participants with high cholesterol. Thus, it is also necessary to consider the possibility that risk was underestimated due to medical therapy for high cholesterol.

Our results are specific to people living in rural areas of Japan and their lifestyle, and may not be applicable to urban Japanese or other ethnic groups. Because Japanese in rural areas have less coronary disease than people in Western countries, their risks from low cholesterol may be higher.

There are many factors that might contribute to the relationship between low cholesterol and high mortality. A correlation between high mortality and low cholesterol clearly exists, especially in populations with a low risk of coronary heart disease.^[@r09]^ Although the dangers of a high cholesterol level are widely known, they are less important in regions---such as rural Japan---where cardiovascular disease is less common. It may therefore be necessary to highlight the risks of low cholesterol. In Japan, only LDL cholesterol and HDL cholesterol are measured at present; however, total cholesterol remains an important measure in predicting mortality.

In conclusion, we observed that low cholesterol was associated with increased risks of cancer, hemorrhagic stroke, and heart failure excluding myocardial infarction.
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